Previous close | 1.1500 |
Open | 1.1500 |
Bid | 1.2500 |
Ask | 1.3500 |
Strike | 2.50 |
Expiry date | 2026-01-16 |
Day's range | 1.1500 - 1.1500 |
Contract range | N/A |
Volume | |
Open interest | 64 |
Discover how Esperion Therapeutics achieved a historic revenue milestone and expanded market potential in its first quarter of 2024.
Significant Growth and FDA Approvals Propel Performance
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 525% and 159.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?